RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status

Published:2012-06-24 Issue:4 Volume:18 Page:783-792
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Omar Mohd Feroz Mohd,Ito Kosei,Nga Min En,Soo Ross,Peh Bee Keow,Ismail Tuty Muliana,Thakkar Bhavin,Soong Richie,Ito Yoshiaki,Salto-Tellez Manuel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-011-9485-5.pdf

Reference59 articles.

1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18(6):1059–1068

2. Mattson ME, Pollack ES, Cullen JW (1987) What are the odds that smoking will kill you? Am J Public Health 77(4):425–431

3. Hessel PA, Gamble JF, McDonald JC (2005) Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. Thorax 60(5):433–436

4. Lubin JH, Boice JD Jr (1997) Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst 89(1):49–57

5. Zhu CQ, Shih W, Ling CH, Tsao MS (2006) Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 59(8):790–800

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CD151 overexpression on prognosis and therapy in non‐small cell lung cancer patients lacking EGFR mutations;Cell Proliferation;2024-07-09

2. RETRACTED: Interplay of microRNAs to genetic, epigenetic, copy number variations of cervical cancer related genes;Journal of Reproductive Immunology;2020-11

3. Lung Cancer Staging and Associated Genetic and Epigenetic Events;MOL CELLS;2020

4. Runx3 and Cell Fate Decisions in Pancreas Cancer;Advances in Experimental Medicine and Biology;2017

5. Clinical Epigenetics of Lung Cancer;Translating Epigenetics to the Clinic;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3